Nadia A. Lanman

2.2k total citations
61 papers, 1.4k citations indexed

About

Nadia A. Lanman is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nadia A. Lanman has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 16 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nadia A. Lanman's work include Immune Cell Function and Interaction (8 papers), Prostate Cancer Treatment and Research (8 papers) and Epigenetics and DNA Methylation (7 papers). Nadia A. Lanman is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Prostate Cancer Treatment and Research (8 papers) and Epigenetics and DNA Methylation (7 papers). Nadia A. Lanman collaborates with scholars based in United States, Canada and France. Nadia A. Lanman's co-authors include Jo Ann Banks, Sandro Matosevic, Sagar M. Utturkar, Jiao Wang, Xiaoqi Liu, Lijun Cheng, Kyle B. Lupo, Elia Farah, Pete E. Pascuzzi and Zhuangzhuang Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Nadia A. Lanman

58 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia A. Lanman United States 24 583 314 265 238 229 61 1.4k
Ying Hu United States 25 1.0k 1.8× 326 1.0× 179 0.7× 219 0.9× 115 0.5× 73 1.7k
Jeong‐Hyeon Choi United States 23 1.2k 2.1× 247 0.8× 229 0.9× 112 0.5× 99 0.4× 40 1.8k
Lina Li China 26 1.2k 2.1× 284 0.9× 150 0.6× 110 0.5× 87 0.4× 90 1.7k
Benjamin Barré France 20 851 1.5× 410 1.3× 219 0.8× 152 0.6× 80 0.3× 30 1.4k
Chang Bai United States 15 1.5k 2.6× 409 1.3× 160 0.6× 296 1.2× 75 0.3× 27 2.3k
Lian Chen China 19 551 0.9× 168 0.5× 109 0.4× 87 0.4× 96 0.4× 41 1.1k
Yunyun Su China 17 508 0.9× 286 0.9× 228 0.9× 322 1.4× 149 0.7× 36 1.3k
Alexandre Soulard France 12 1.9k 3.3× 207 0.7× 115 0.4× 280 1.2× 39 0.2× 18 2.4k
Sanjit K. Roy United States 21 998 1.7× 518 1.6× 352 1.3× 36 0.2× 100 0.4× 41 1.7k
Kyunghwan Kim South Korea 27 1.5k 2.5× 236 0.8× 123 0.5× 479 2.0× 53 0.2× 76 2.1k

Countries citing papers authored by Nadia A. Lanman

Since Specialization
Citations

This map shows the geographic impact of Nadia A. Lanman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia A. Lanman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia A. Lanman more than expected).

Fields of papers citing papers by Nadia A. Lanman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia A. Lanman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia A. Lanman. The network helps show where Nadia A. Lanman may publish in the future.

Co-authorship network of co-authors of Nadia A. Lanman

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia A. Lanman. A scholar is included among the top collaborators of Nadia A. Lanman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia A. Lanman. Nadia A. Lanman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lubecka, Katarzyna, Sandra Torregrosa‐Allen, Bennett D. Elzey, et al.. (2025). AMPK‐Dependent Epigenetic Regulation of Metabolism Mediates the Anti‐Cancer Action of Pterostilbene in Hepatocellular Carcinoma. Molecular Nutrition & Food Research. 69(23). e70217–e70217.
2.
Vickman, Renee E., et al.. (2024). Characterization of prostate macrophage heterogeneity, foam cell markers, and CXCL17 upregulation in a mouse model of steroid hormone imbalance. Scientific Reports. 14(1). 21029–21029. 5 indexed citations
3.
Mall, G., Alisha Dhiman, Isabel A. English, et al.. (2024). KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development. Oncogene. 43(50). 3673–3687. 2 indexed citations
4.
Li, Zhili, Sagar M. Utturkar, Bingyu Yan, et al.. (2024). DDX5 deficiency drives non-canonical NF-κB activation and NRF2 expression, influencing sorafenib response and hepatocellular carcinoma progression. Cell Death and Disease. 15(8). 583–583. 4 indexed citations
5.
Terwilliger, Emma, Claire M. Pfeffer, Sagar M. Utturkar, et al.. (2024). miR-497 Target Gene Regulatory Network in Angiosarcoma. Molecular Cancer Research. 22(9). 879–890. 7 indexed citations
6.
Singh, Parmveer, Nadia A. Lanman, Laura Wilson, et al.. (2023). Human prostate organoid generation and the identification of prostate development drivers using inductive rodent tissues. Development. 150(13). 1 indexed citations
7.
Lanman, Nadia A., et al.. (2023). Abstract 4752: Loss of the methyltransferase KMT5C drives resistance to tyrosine kinase inhibitors via H4K20me3 regulation in non-small cell lung cancer. Cancer Research. 83(7_Supplement). 4752–4752. 1 indexed citations
8.
Li, Zhili, Claude Caron de Fromentel, Wen‐Hung Wang, et al.. (2023). RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin–ferroptosis axis. Cell Death and Disease. 14(11). 786–786. 23 indexed citations
9.
Lanman, Nadia A., et al.. (2022). Proper control of R‐loop homeostasis is required for maintenance of gene expression and neuronal function during aging. Aging Cell. 21(2). e13554–e13554. 23 indexed citations
10.
11.
Zhang, Zhuangzhuang, Lijun Cheng, Jie Li, et al.. (2022). Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy. Cancer Research. 82(19). 3532–3548. 36 indexed citations
12.
Lanman, Nadia A., et al.. (2022). Loss of KMT5C Promotes EGFR Inhibitor Resistance in NSCLC via LINC01510-Mediated Upregulation of MET. Cancer Research. 82(8). 1534–1547. 30 indexed citations
13.
Bowers, Laura W., Nadia A. Lanman, Caroline Himbert, et al.. (2022). Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer. Cancer Prevention Research. 15(8). 481–495. 7 indexed citations
14.
Deen, Nataly Naser Al, Nadia A. Lanman, Shirisha Chittiboyina, et al.. (2021). A risk progression breast epithelial 3D culture model reveals Cx43/hsa_circ_0077755/miR-182 as a biomarker axis for heightened risk of breast cancer initiation. Scientific Reports. 11(1). 2626–2626. 10 indexed citations
15.
Mohammed, Sulma I., Sagar M. Utturkar, Maxwell Lee, et al.. (2020). Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer. Cancers. 12(2). 418–418. 17 indexed citations
16.
Yang, Yi, Nadia A. Lanman, Brett P. Monia, et al.. (2019). Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1–Dependent Immune Evasion. Cancer Research. 79(13). 3417–3430. 60 indexed citations
17.
Vickman, Renee E., Jiang Yang, Nadia A. Lanman, et al.. (2019). Cholesterol Sulfotransferase SULT2B1b Modulates Sensitivity to Death Receptor Ligand TNFα in Castration-Resistant Prostate Cancer. Molecular Cancer Research. 17(6). 1253–1263. 8 indexed citations
18.
Yang, Jiang, et al.. (2019). Distinct expression patterns of SULT2B1b in human prostate epithelium. The Prostate. 79(11). 1256–1266. 4 indexed citations
19.
Zhang, Zhuangzhuang, Lijun Cheng, Jie Li, et al.. (2018). Inhibition of the Wnt/β-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer. Cancer Research. 78(12). 3147–3162. 123 indexed citations
20.
Shah, Fenil, et al.. (2017). APE1/Ref-1 knockdown in pancreatic ductal adenocarcinoma – characterizing gene expression changes and identifying novel pathways using single-cell RNA sequencing. Publisher.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying Hu Breakdown of academic impact, for papers by Jeong‐Hyeon Choi Breakdown of academic impact, for papers by Lina Li Breakdown of academic impact, for papers by Benjamin Barré Breakdown of academic impact, for papers by Chang Bai Breakdown of academic impact, for papers by Lian Chen Breakdown of academic impact, for papers by Yunyun Su Breakdown of academic impact, for papers by Alexandre Soulard Breakdown of academic impact, for papers by Sanjit K. Roy Breakdown of academic impact, for papers by Kyunghwan Kim
Rankless by CCL
2026